Page last updated: 2024-08-26

3-hydroxyphthalic anhydride and HIV Coinfection

3-hydroxyphthalic anhydride has been researched along with HIV Coinfection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
An, X; Guo, X; He, L; Jiang, S; Li, L; Liu, S; Lu, H; Pan, C; Qi, Z; Tan, S1
Jiang, S; Jin, H; Li, L; Liu, S; Lu, H; Lu, L; Tan, S; Yang, J1

Other Studies

2 other study(ies) available for 3-hydroxyphthalic anhydride and HIV Coinfection

ArticleYear
3-hydroxyphthalic anhydride-modified chicken ovalbumin exhibits potent and broad anti-HIV-1 activity: a potential microbicide for preventing sexual transmission of HIV-1.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Animals; Anti-HIV Agents; Arginine; Chickens; CHO Cells; Cricetinae; Cricetulus; Drug Design; Epithelial Cells; Female; HIV Envelope Protein gp41; HIV Infections; HIV-1; HIV-2; Humans; Interferon-gamma; Leukocytes, Mononuclear; Lysine; Membrane Fusion; Molecular Weight; Ovalbumin; Phthalic Anhydrides; Protein Structure, Secondary; Sexually Transmitted Diseases, Viral; Simian Immunodeficiency Virus

2010
Combinations of 3-hydroxyphthalic anhydride-modified ovalbumin with antiretroviral drug-based microbicide candidates display synergistic and complementary effects against HIV-1 infection.
    Journal of acquired immune deficiency syndromes (1999), 2011, Apr-15, Volume: 56, Issue:5

    Topics: Animals; Anti-HIV Agents; Chickens; Disease Transmission, Infectious; Drug Synergism; Drug Therapy, Combination; Female; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Ovalbumin; Phthalic Anhydrides; Rats; Reverse Transcriptase Inhibitors; Treatment Outcome

2011